中华医学会烧伤外科学分会青年委员会 副主任委员
Vice Chairman of the Youth Committee of the Burn Surgery Branch of Chinese Medical Association
中国医师协会创伤外科学分会 委员
Member of Trauma Surgery Branch of Chinese Medical Doctor Association
全军重症医学专业委员会 青年委员
Youth member of the Critical Care Medicine Professional Committee of the PLA
中国医药生物技术协会皮肤软组织修复与重建技术分会 副主任委员
Vice Chairman of Skin and Soft tissue Repair and Reconstruction Technology Branch of China Medical Biotechnology Association
中国医药教育协会血栓与止血危重病专业委员会 副主任委员
Vice Chairman of Chinese Society of Thrombosis, Hemostasis and Critical Care of China Medical Education Association
中国老年医学学会烧创伤分会 常委兼副总干事
member of the standing committee and vice secretary-general, Burn and Trauma branch of Chinese Geriatrics Society
上海市中西医结合学会灾害医学专委会 副主任委员
Vice Chairman of disaster Medicine Special Committee of Shanghai Society of Integrated Traditional Chinese and Western Medicine
上海市中医药学会创伤康复分会 常务委员
Standing member of Trauma Rehabilitation Branch of Shanghai Society of Traditional Chinese Medicine
上海市医学会烧伤外科第八届🫑、第九届委员会委员
Member of the eighth and ninth Committee of the Burn Surgery of Shanghai Medical Association
美国心脏病学会🦔、灾难医学会和创伤医学会BLS🏂🏿、ACLS🧝🏼、NDLS😯、PHTLS导师
BLS, ACLS, NDLS, PHTLS mentors, American College of Cardiology, Society of Disaster and Society of Trauma
主持国家重点研发计划“干细胞及转化研究”重点专项🖖🏼🎞、国家自然科学基金以及各级省部校级课题等项目15项。发表论文130余篇，SCI 50余篇🐸。发布临床共识11部👋，主编英文专著1部，主编和参编中文论著11部，主译专著2部🧑🏻🍼。获专利13项✍🏽👩🏻🏭。Burns & Trauma第一🫴🏽、第二届青年编委，《中华损伤与修复杂志（电子版）》、《血栓与止血学》编委，《中华烧伤与创面修复杂志》通讯编委👨💻。获树兰医学青年奖提名🥵、王正国创伤医学奖突出贡献奖提名🙇♂️。牵头执笔的《成人烧伤俯卧位治疗全国专家共识（2022版）》被评为2022年度TOP300指南/共识并获得“共识制定透明奖”。获评《凝血功能障碍诊断规范》团体标准先进个人。《中华烧伤杂志》优秀通讯编委奖。
1.2006年开始关注间充质干细胞及其衍生物治疗肺损伤动态💺，创新性总结MSCs治疗吸入性损伤六大机制🏋🏻♀️。揭示了雾化脐带间充质干细胞来源外泌体（UCMSC-Exos）治疗小鼠ALI“倒U形”剂量效应关系及其潜在机制🏄♀️。开展多批次脐带间充质干细胞临床安全性和有效性研究，建立健全临床干细胞使用安全性处置和有效性评估，建立符合临床规范和要求的🤸♀️、可操作性的干细胞治疗流程🩱🫃🏽。
2.聚焦烧创伤相关肺损伤💅，系统开展基础研究和临床实践🧑🏽🦰，提出基于ALI机制及预警能力的干细胞防治策略🧏🏽♀️✡️，打造预警和救治网络。
3.国内较早开展烧创伤后凝血障碍基础研究和临床转化。1）揭示烧创伤后早期凝血特征和预警价值👨🏼🍼⛴，提出烧伤性凝血病诊断标准🐙。2）聚焦重症患者和特殊人群血小板减少症与VTE，提出免疫血栓/NETs/NETosis 导向SIC/SA-DIC的抗凝理念和策略💝。牵头和参与制定了多部重症烧创伤凝血相关中国专家共识1️⃣，主编《弥散性血管内凝血》。
Prof. Zhu Led 15 projects including the National Key Research and Development Program on Stem Cell and Translation Research, National Natural Science Foundation of China, and various provincial, ministerial, and university-level research topics, published over 130 papers, more than 50 of which are indexed in the Science Citation Index (SCI), and contributed to the development of 11 clinical guidelines or consensuses.
Served as the chief editor, Prof. Zhu completed one English-language monograph, participated in the editing of 11 Chinese monographs, and translated two monographs. Furthermore Prof. Zhu obtained 13 patents.
Prof. Zhu served as a young editorial board member for the first and second editions of Burns & Trauma（Top publication in the field of burns）, and as an editorial board member for the Chinese Journal of Trauma and Repair (Electronic Edition) and Thrombosis and Hemostasis , and a corresponding editorial board member for the Chinese Journal of Burns and Wound Repair（Top Chinese publications in the field of burns and coagulation）.
Prof. Zhu acted as a reviewer for the National Natural Science Foundation of China, nominated for ‘Shulan Medical Youth Award’ and ‘WangZhengguo Traumatology Award’ for outstanding contribution. The lead-authored "National Expert Consensus on Prone Position Treatment for Adult Burns (2022 Edition)" has been recognized as one of the Top 300 Guidelines/Consensus Statements of 2022 and has been awarded the "Transparency in Guideline Development Award." Recognized as an advanced individual for the "Diagnostic Standard for Coagulation Dysfunction" group standard. Prof. Zhu awarded the ‘Outstanding Corresponding Editorial Board Member’ of the Chinese Journal of Burns.
1.Since 2006, attention has been directed towards the dynamics of mesenchymal stem cells (MSCs) and their derivatives in treatment of lung injury by Prof. Zhu and his team, leading to an innovative summary of the six major mechanisms by which MSCs treat inhalation injury. The dose-response relationship of inhaled exosomes derived from umbilical cord mesenchymal stem cells (UCMSCs-Exos) in treating acute lung injury (ALI) in mice has been elucidated by Prof. Zhu and his team, revealing an ‘inverted U-shaped’ dose-effect relationship and its potential mechanisms. Multiple batches of UCMSCs have been subjected to clinical studies to assess their safety and efficacy, establishing a comprehensive safety management and efficacy evaluation system for clinical stem cell use. A standardized and operational stem cell therapy protocol has been developed, adhering to clinical norms and requirements, to ensure the safe and effective application of stem cells in clinical settings. This protocol encompasses the entire process from stem cell preparation to administration, including quality control, safety monitoring, and efficacy assessment, to optimize patient outcomes in lung injury treatments.
2.Focusing on burns and trauma related to lung injuries, Prof. Zhu have systematically carried out basic research and clinical practice. This has led to the proposition of a stem cell prevention and treatment strategy based on the understanding of ALI mechanisms and early warning capabilities with the aim to establish an integrated network for early warning and effective treatment, enhancing the management of such critical conditions.
3.Prof. Zhu and his team have been among the first in China to conduct basic research and clinical translation on coagulopathy after burns and trauma. 1) To revealed the early coagulation characteristics and predictive value after burns and trauma, proposing diagnostic criteria for burn-induced coagulopathy. 2) Focusing on thrombocytopenia and venous thromboembolism (VTE) in critically ill patients and special populations, Prof. Zhu and his team have proposed an anticoagulation philosophy and strategy directed towards immunothrombosis, neutrophil extracellular traps (NETs), and NETosis in the context of sepsis-induced coagulopathy (SIC) and shock-associated disseminated intravascular coagulation (SA-DIC). They have led and participated in the formulation of multiple Chinese expert consensus guidelines on coagulation-related issues in severe burns and trauma, and Prof. Zhu is the chief editor of the book ‘Disseminated Intravascular Coagulation’.
